Louisa Lytton

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Intel CEO faces resignation calls over alleged China ties, raising national security concerns.
  • Firefly Aerospace's successful Nasdaq debut, raising $868M and reaching a valuation close to $10B, reflects strong investor enthusiasm for its space technology.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Intel CEO faces resignation calls over alleged China ties, raising national security concerns.
  • Firefly Aerospace's successful Nasdaq debut, raising $868M and reaching a valuation close to $10B, reflects strong investor enthusiasm for its space technology.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Louisa Lytton